ResearcherVall d'Hebron Hospital UniversitariNo recent work listed
Helena Verdaguer
Matched on ORCID iD 0000-0001-6163-382X; OpenAlex author ID A5054454777. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 22
2017: 1 paper · 2018: 1 paper · 2019: none · 2020: 2 papers · 2021: 1 paper · 2022: none · 2023: 1 paper
Papers 6
- ACT-Discover: identifying karyotype heterogeneity in pancreatic cancer evolution using ctDNA. Co-author DOI 10.1186/s13073-023-01171-w↗
- Emerging Treatment Strategies in Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000001845↗
- Quality of life of patients with metastatic pancreatic adenocarcinoma initiating first-line chemotherapy in routine practice. Co-author DOI 10.1186/s12904-020-00610-4↗
- A new targeted treatment for patients with a germline BRCA mutation: olaparib in pancreatic cancer. Co-author DOI 10.2217/fon-2020-0334↗
- New Horizons in the Treatment of Metastatic Pancreatic Cancer: A Review of the Key Biology Features and the Most Recent Advances to Treat Metastatic Pancreatic… Co-author DOI 10.1007/s11523-018-0609-7↗
- Initial Experience in the Treatment of "Borderline Resectable" Pancreatic Adenocarcinoma. Co-author DOI 10.1016/j.ciresp.2017.07.008↗
Closest collaborators
The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Teresa Mercade Macarulla · 5 shared papers, 2018–2023 · strength 0.72
- Paper A new targeted treatment for patients with a germline BRCA mutation: olaparib in pancreatic cancer. DOI 10.2217/fon-2020-0334↗
- Paper Emerging Treatment Strategies in Pancreatic Cancer. DOI 10.1097/mpa.0000000000001845↗
- Paper ACT-Discover: identifying karyotype heterogeneity in pancreatic cancer evolution using ctDNA. DOI 10.1186/s13073-023-01171-w↗
- Laura K. Miotke · 1 shared paper, 2021 · strength 0.16
- Andrew D. Trunk · 1 shared paper, 2021 · strength 0.16
- Chris Nevala-Plagemann · 1 shared paper, 2021 · strength 0.16
- Ignacio Garrido‐Laguna · 1 shared paper, 2021 · strength 0.16
- Berta Laquente · 2 shared papers, 2017–2020 · strength 0.16
- Ariana Huebner · 1 shared paper, 2023 · strength 0.15
- Rocio García‐Carbonero · 1 shared paper, 2023 · strength 0.15
- Francesca Sarno · 1 shared paper, 2023 · strength 0.15
- Rodrigo Almeida Toledo · 1 shared paper, 2023 · strength 0.15
- Roberto Pazo-Cid · 1 shared paper, 2023 · strength 0.15
- Manuel M. Hidalgo · 1 shared paper, 2023 · strength 0.15
- Carmen Guillén‐Ponce · 1 shared paper, 2023 · strength 0.15
- Jaime Feliú · 1 shared paper, 2023 · strength 0.15
- Adelaida Garcia-Velasco · 1 shared paper, 2020 · strength 0.09
- Carles Pericay Pijaume · 1 shared paper, 2020 · strength 0.09
- Marta Martín-Richard · 1 shared paper, 2020 · strength 0.09
- Laura Visa · 1 shared paper, 2020 · strength 0.09
- Juan Fabregat · 1 shared paper, 2017 · strength 0.06
- Emilio Ramos Rubio · 1 shared paper, 2017 · strength 0.06
- Lluís Secanella · 1 shared paper, 2017 · strength 0.06
- Juli Busquets · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.